| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 23.22B | 23.63B | 20.71B | 20.35B | 19.04B | 16.97B |
| Gross Profit | 7.93B | 8.01B | 6.68B | 6.27B | 6.27B | 5.56B |
| EBITDA | 4.66B | 3.95B | 3.14B | 2.96B | 3.29B | 2.62B |
| Net Income | 2.29B | 2.47B | 1.91B | 1.68B | 2.05B | 1.50B |
Balance Sheet | ||||||
| Total Assets | 26.93B | 27.00B | 27.92B | 26.51B | 25.88B | 24.94B |
| Cash, Cash Equivalents and Short-Term Investments | 8.28B | 7.92B | 6.54B | 5.93B | 5.54B | 5.32B |
| Total Debt | 642.70M | 17.27M | 21.37M | 23.94M | 26.99M | 20.00M |
| Total Liabilities | 4.75B | 5.10B | 4.81B | 4.61B | 4.39B | 4.41B |
| Stockholders Equity | 22.18B | 21.90B | 23.11B | 21.90B | 21.49B | 20.53B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.20B | 1.13B | 538.07M | 1.55B | 1.84B |
| Operating Cash Flow | 0.00 | 3.59B | 1.84B | 947.42M | 1.79B | 2.41B |
| Investing Cash Flow | 0.00 | 182.80M | -281.44M | 716.59M | -604.65M | -1.46B |
| Financing Cash Flow | 0.00 | -3.68B | -883.04M | -1.18B | -862.55M | -355.80M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥45.79B | 15.81 | ― | 1.92% | -0.86% | 17.65% | |
78 Outperform | ¥32.29B | 12.49 | ― | 1.89% | 2.15% | 16.14% | |
77 Outperform | ¥48.63B | 11.38 | ― | 2.22% | 5.17% | 79.36% | |
76 Outperform | ¥88.89B | 23.41 | ― | 1.24% | 8.78% | 19.37% | |
75 Outperform | ¥26.18B | 14.09 | ― | 3.24% | 1.83% | -8.54% | |
67 Neutral | ¥31.91B | 17.11 | ― | 2.37% | -11.70% | -54.82% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
Ishihara Chemical Co., Ltd. announced a change in its major shareholder, with Simplex Asset Management Co., Ltd. increasing its stake to 10.70% as of October 15, 2025. This change, confirmed through a report submitted to the Kanto Local Finance Bureau, may impact the company’s shareholder dynamics but does not have any immediate special implications for its future outlook.
Ishihara Chemical Co., Ltd. reported a decline in its consolidated financial results for the six months ended September 30, 2025, with net sales and profits showing a decrease compared to the previous year. Despite the downturn, the company maintains a strong equity-to-asset ratio and has announced a forecast for the fiscal year ending March 31, 2026, with expectations of modest growth in net sales and profits, indicating resilience and strategic planning to navigate current market challenges.
Ishihara Chemical Co., Ltd. has established a wholly-owned subsidiary in Shanghai, China, named Ishihara Chemical (Shanghai) Technology Co., Ltd. This move aims to enhance the company’s supply chain stability and adaptability to local demands in China. The new subsidiary will focus on manufacturing and selling electronic-related chemical products. Although the financial impact on the company’s results for the fiscal year ending March 31, 2026, is expected to be minimal, this strategic expansion could strengthen Ishihara Chemical’s market position in the region.